A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease ...

CBT-I Is the evidence-based first-line treatment, but access gaps persist.

The FDA has accepted for review the BLA for nanoencapsulated sirolimus plus pegadricase in the treatment of uncontrolled gout.